STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
· statnews.com · popularity 34/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at statnews.com →
Summary
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 1.